肺癌ADJUVANT研究课件

wo patients in the gefitinib arm and one patient in the vinorelbine plus cisplatin armРAbstract 8500 presented by Y-L Wu ?Guangdong Lung Cancer Institute,Guangdong General Hospital, ChinaР基线人口统计学特征(ITT人群)Р长春瑞滨+顺铂(n=111)Р吉非替尼(n=111)РEGFR 突变状态, n (%)?Exon 19 deletion?Exon 21 L858R?EGFR 假阳性Р57 (51.4)?53 (47.7)?1 (0.9)Р58 (52.3)?53 (47.7)?0 (0)Р淋巴结状态, n (%)?N1?N2?Not availableР37 (33.3)?72 (64.9)?2 (1.8)Р40 (36.0)?71 (64.0)?0 (0)Р切除类型, n (%)?肺叶切除术?双肺叶切除术?全肺切除术?楔形切除术?Not availableР91 (82.0)?14 (12.6)?3 (2.7)?2 (1.8)?1 (0.9)Р93 (83.8)?13 (11.7)?3 (2.7)?0 (0)?2 (1.8)РAbstract 8500 presented by Y-L Wu ?Guangdong Lung Cancer Institute,Guangdong General Hospital, ChinaР10Р药物暴露Р<6Р6.1–12Р12.1–18Р>18.1РAbstract 8500 presented by Y-L Wu ?Guangdong Lung Cancer Institute,Guangdong General Hospital, China